Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Amneal Pharmaceuticals stock | $5.66

Learn how to easily invest in Amneal Pharmaceuticals stock.

Amneal Pharmaceuticals, Inc
NYSE: AMRX - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$0
-

Amneal Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Amneal Pharmaceuticals shares (AMRX) are listed on the NYSE and all prices are listed in US Dollars. Amneal Pharmaceuticals employs 6,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amneal Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Amneal Pharmaceuticals stock price (NYSE: AMRX)

Use our graph to track the performance of AMRX stocks over time.

Amneal Pharmaceuticals shares at a glance

Information last updated 2021-07-28.
Latest market close$5.66
52-week range$3.45 - $7.45
50-day moving average $5.11
200-day moving average $5.53
Wall St. target price$6.69
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.61

Buy Amneal Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amneal Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amneal Pharmaceuticals price performance over time

Historical closes compared with the close of $5.66 from 2021-05-28

1 week (2021-07-21) N/A
1 month (2021-07-01) 7.20%
3 months (2021-04-30) 2.72%
6 months (2021-01-28) N/A
1 year (2020-07-28) N/A
2 years (2019-07-28) N/A
3 years (2018-07-28) N/A
5 years (2016-07-28) N/A

Is Amneal Pharmaceuticals under- or over-valued?

Valuing Amneal Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amneal Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amneal Pharmaceuticals's EBITDA

Amneal Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $358.3 million.

The EBITDA is a measure of a Amneal Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Amneal Pharmaceuticals financials

Revenue TTM $2 billion
Operating margin TTM 6.31%
Gross profit TTM $652.3 million
Return on assets TTM 1.88%
Return on equity TTM -9.65%
Profit margin -0.87%
Book value $2.17
Market capitalisation $736.2 million

TTM: trailing 12 months

Shorting Amneal Pharmaceuticals shares

There are currently 4.8 million Amneal Pharmaceuticals shares held short by investors – that's known as Amneal Pharmaceuticals's "short interest". This figure is 6.5% up from 4.5 million last month.

There are a few different ways that this level of interest in shorting Amneal Pharmaceuticals shares can be evaluated.

Amneal Pharmaceuticals's "short interest ratio" (SIR)

Amneal Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Amneal Pharmaceuticals shares currently shorted divided by the average quantity of Amneal Pharmaceuticals shares traded daily (recently around 855660.42780749). Amneal Pharmaceuticals's SIR currently stands at 5.61. In other words for every 100,000 Amneal Pharmaceuticals shares traded daily on the market, roughly 5610 shares are currently held short.

However Amneal Pharmaceuticals's short interest can also be evaluated against the total number of Amneal Pharmaceuticals shares, or, against the total number of tradable Amneal Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amneal Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Amneal Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0504% of the tradable shares (for every 100,000 tradable Amneal Pharmaceuticals shares, roughly 50 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amneal Pharmaceuticals.

Find out more about how you can short Amneal Pharmaceuticals stock.

Amneal Pharmaceuticals share dividends

We're not expecting Amneal Pharmaceuticals to pay a dividend over the next 12 months.

Amneal Pharmaceuticals share price volatility

Over the last 12 months, Amneal Pharmaceuticals's shares have ranged in value from as little as $3.45 up to $7.445. A popular way to gauge a stock's volatility is its "beta".

AMRX.US volatility(beta: 1.26)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amneal Pharmaceuticals's is 1.2647. This would suggest that Amneal Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Amneal Pharmaceuticals overview

Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.

Frequently asked questions

What percentage of Amneal Pharmaceuticals is owned by insiders or institutions?
Currently 10.551% of Amneal Pharmaceuticals shares are held by insiders and 70.302% by institutions.
How many people work for Amneal Pharmaceuticals?
Latest data suggests 6,000 work at Amneal Pharmaceuticals.
When does the fiscal year end for Amneal Pharmaceuticals?
Amneal Pharmaceuticals's fiscal year ends in December.
Where is Amneal Pharmaceuticals based?
Amneal Pharmaceuticals's address is: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
What is Amneal Pharmaceuticals's ISIN number?
Amneal Pharmaceuticals's international securities identification number is: US03168L1052
What is Amneal Pharmaceuticals's CUSIP number?
Amneal Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 03168L105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site